Literature DB >> 17401699

[Importance of the history and the utilization of therapy guidelines in patients with arrhythmias].

M Meesmann1.   

Abstract

In this article criteria for taking the history in patients with manifest or potential life threatening arrhythmias are outlined. The importance of a sound (family) history is demonstrated. Besides specific correlates for arrhythmias in the history of a patient, the long term consequences of dyspnoe on exertion and hypertension are outlined. In 80% of patients sudden death is due to myocardial ischemia or interstitial myocardial fibrosis which in turn result from acquired diseases such as coronary artery disease and hypertension. Against this background the importance of the prevention of sudden cardiac death by nonantiarrhythmics drugs is stressed. Examples of under-utilization of therapy guidelines are given with special reference to beta-blocker therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401699     DOI: 10.1007/s00399-007-0556-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  13 in total

Review 1.  Sudden cardiac death and inherited arrhythmia syndromes.

Authors:  Andrea Sarkozy; Pedro Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2005-09

2.  [Guidelines for therapy of chronic heart failure].

Authors:  U C Hoppe; M Böhm; R Dietz; P Hanrath; H K Kroemer; A Osterspey; A A Schmaltz; E Erdmann
Journal:  Z Kardiol       Date:  2005-08

3.  [Guidelines for the implantation of defibrillators].

Authors:  W Jung; D Andresen; M Block; D Böcker; S H Hohnloser; K-H Kuck; J Sperzel
Journal:  Clin Res Cardiol       Date:  2006-12       Impact factor: 5.460

4.  Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.

Authors:  Mattie J Lenzen; Eric Boersma; Wilma J M Scholte Op Reimer; Aggie H M M Balk; Michel Komajda; Karl Swedberg; Ferenc Follath; Manuel Jimenez-Navarro; Maarten L Simoons; John G F Cleland
Journal:  Eur Heart J       Date:  2005-09-23       Impact factor: 29.983

Review 5.  Sudden cardiac death: exploring the limits of our knowledge.

Authors:  R J Myerburg
Journal:  J Cardiovasc Electrophysiol       Date:  2001-03

6.  Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.

Authors:  Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip Poole-Wilson; Claude Le Pen
Journal:  Eur Heart J       Date:  2005-04-12       Impact factor: 29.983

7.  Prognostic significance of dyspnea in patients referred for cardiac stress testing.

Authors:  Aiden Abidov; Alan Rozanski; Rory Hachamovitch; Sean W Hayes; Fatma Aboul-Enein; Ishac Cohen; John D Friedman; Guido Germano; Daniel S Berman
Journal:  N Engl J Med       Date:  2005-11-03       Impact factor: 91.245

8.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.

Authors:  Paul G Shekelle; Michael W Rich; Sally C Morton; Col Sid W Atkinson; Wenli Tu; Margaret Maglione; Shannon Rhodes; Michael Barrett; Gregg C Fonarow; Barry Greenberg; Paul A Heidenreich; Tom Knabel; Marvin A Konstam; Anthony Steimle; Lynne Warner Stevenson
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

10.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

Authors:  Thomas Fetsch; Peter Bauer; Rolf Engberding; Hans P Koch; Jan Lukl; Thomas Meinertz; Michael Oeff; Ludger Seipel; Hans J Trappe; Norbert Treese; Günter Breithardt
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

View more
  1 in total

1.  [Orthostatic hypotension : diagnosis and therapy].

Authors:  R Schimpf; C Veltmann; M Borggrefe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.